In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and bay l 9139

Robert A. Fromtling Department of Medicine, Medical College of Virginia, Virginia Commonwealth University Richmond, Virginia, U.S.A.; Clinical Microbiology, Columbia-Presbyterian Medical Center, New York, New York, U.S.A.

Hung-Pui Yu Department of Microbiology and Immunology, Medical College of Virginia, Virginia Commonwealth University Richmond, Virginia, U.S.A.

Smith Shadomy Department of Basic Microbiology, Merck Institute for Therapeutic Research, Rahway, New Jersey, U.S.A.

References

Borelli D., Bran J.L., Fuentes J., Legendre R., Leiderman E., Levine H.B., Restrepo A., Stevens D.A. Ketoconazole, an oral antifungal: laboratory and clinical assessment of imidazole drugs. Postgraduate Medical Journal 1979; 55: 657–661
PubMed Web of Science ®Google Scholar
Dixon D., Shadomy S., Shadomy H.J., Espinel-Ingroff A., Kerkering T.M. Comparison of the in vitro antifungal activities of miconazole and a new imidazole, R41,400. Journal of Infectious Diseases 1978; 138: 245–248
PubMed Web of Science ®Google Scholar
Holt R.J. Recent developments in antimycotic chemotherapy. Infection 1974; 2: 95–107
PubMed Web of Science ®Google Scholar
Yamaguchi T., Hiratani T., Plempel M. In vitro studies of a new oral azole antimycotic, BAY n 7133. Journal of Antimicrobial Chemotherapy 1983; 11: 135–149
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and bay l 9139

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

In-vitro inhibitory activities of 2 new orally absorbable imidazole derivatives: Bay n 7133 and bay l 9139

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date